$113.39
-0.38-0.33%
Últ. Act.: Nov 6, 4:00 PM
Agilon Health (AGL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $1.97 | $-0.99 | 299.0 % |
| Q2 | Aug 5, 2026 | $1.04 | $0.14 | 642.9 % |
| Q1 | May 6, 2026 | $1.80 | $0.95 | 89.5 % |
| Q4 | Feb 25, 2026 | $-11.50 | $-6.75 | -70.4 % |
Quarterly Revenue (Billions)
Agilon Health (AGL) publicó su última previsión de noviembre 4, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $5.87B - $5.89B para el período.
En comparación con la previsión anterior, Agilon Health elevado redujo su previsión de ingresos desde un rango anterior de $5.78B - $5.86B.
Agilon Health ha emitido 27 actualizaciones de orientación entre el marzo 1, 2023 y el noviembre 4, 2026. During this period, the company raised its outlook 8 times and lowered it 14 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.99 | $0.14 | $0.95 | $-6.75 |
| Actual | $1.97 | $1.04 | $1.80 | $-11.50 |
| Surprise | +299.0% | +642.9% | +89.5% | -70.4% |
| Revenue | ||||
| Estimate | $1.46B | $1.45B | $1.38B | $1.46B |
| Actual | $1.52B | $1.49B | $1.42B | $1.57B |
| Surprise | +4.12% | +3.11% | +2.94% | +7.40% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-3.11 | $2.14 | $3.84 | $-0.46 |
| Revenue | ||||
| Consensus | $1.45B | $1.53B | — | — |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $1.52B | $1.46B | 4.12 % |
| Q2 | Aug 5, 2026 | $1.49B | $1.45B | 3.11 % |
| Q1 | May 6, 2026 | $1.42B | $1.38B | 2.94 % |
| Q4 | Feb 25, 2026 | $1.57B | $1.46B | 7.40 % |